The AHA recommended whole exome or whole genome sequencing as first-line diagnostic tools for mitochondrial diseases.

Advancements in AI, multi-omics, and genome editing are transforming life sciences and biotechnology, addressing new ...

Researchers explored a novel strategy involving CRISPR–Cas3 and investigated its potential using a mouse model of ...

Genetic disorders occur due to alterations in the primary genetic material, deoxyribonucleic acid (DNA), of an organism.

CRISPR–Cas9-based therapies are widely investigated for their clinical applications. However, there are limitations ...

Precision BioSciences, Inc. , a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to ...

Gene-editing technologies show great promise for medical treatments and research, with the potential to cure thousands of ...

Scientists have discovered a new CRISPR mechanism with precise activity, expanding the potential applications of the existing CRISPR toolbox.

Researchers uncovered a previously unknown CRISPR immune response in bacteria that targets transfer RNAs. The newly identified nuclease Cas12a3 precisely cuts the conserved tRNA tail, halting protein ...